Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication

GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication
ShareXFacebook

(MedPage Today) -- CHICAGO -- Use of GLP-1 receptor agonists was tied to significantly lower risks of major diabetic foot complications compared with SGLT2 inhibitors in adults with type 2 diabetes, a large, real-world analysis indicated. Compared...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

In Our Dog-Eat-Dog Medical Culture, Physicians Lose
MedPage Today

In Our Dog-Eat-Dog Medical Culture, Physicians Lose

(MedPage Today) -- For years, physicians have voiced the same frustrations: declining reimbursement, increasing administrative burden, private equity infiltration, insurance company control, expanding scope creep, artificial intelligence (AI) anxiety...

Read more →
Advertisement